-
1
المؤلفون: D. I. Abdulganieva, A. L. Bakulev, E. A. Belousova, L. F. Znamenskaya, T. V. Korotaeva, L. S. Kruglova, M. M. Kokhan, A. M. Lila, V. R. Khayrutdinov, I. L. Khalif, M. M. Khobeysh
المصدر: Alʹmanah Kliničeskoj Mediciny, Vol 46, Iss 5, Pp 426-444 (2018)
مصطلحات موضوعية: medicine.medical_specialty, crohn's disease, Context (language use), Scientific expertise, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, inflammatory bowel disease, medicine, ulcerative colitis, 030203 arthritis & rheumatology, Polypharmacy, psoriatic arthritis, business.industry, Genetically engineered, General Medicine, psoriasis, medicine.disease, Il23r gene, Family medicine, Medicine, business, Specialist Physician, interdisciplinary guidelines
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf738b9aa880a9a6cac598f5dad7ef36Test
https://www.almclinmed.ru/jour/article/view/881Test -
2
المؤلفون: A. A. Bakulev
المصدر: Vestnik Dermatologii i Venerologii, Vol 0, Iss 5, Pp 89-96 (2018)
مصطلحات موضوعية: medicine.medical_specialty, Response to therapy, aprimilast, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, soriasis, 0302 clinical medicine, Immune pathogenesis, Psoriasis, comorbid states, medicine, lcsh:Dermatology, psoriatic arthritis, therapy, business.industry, Genetically engineered, pathogenesis, Moderate to severe psoriasis, psoriasis, lcsh:RL1-803, medicine.disease, Dermatology, Clinical trial, immune system, small molecules, efficiency, 030220 oncology & carcinogenesis, Apremilast, business, medicine.drug, recommendations for use
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::775f57851813a4df13d0f85d7dd63fbfTest
https://www.vestnikdv.ru/jour/article/view/343Test -
3
المؤلفون: A. L. Bakulev
المصدر: Vestnik Dermatologii i Venerologii, Vol 0, Iss 5, Pp 32-38 (2017)
مصطلحات موضوعية: safety, medicine.medical_specialty, genetically engineered biological drugs, псориаз, immunogenicity, Biological drugs, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, иммуногенность, Psoriasis, lcsh:Dermatology, Medicine, Severe psoriasis, Intensive care medicine, секукинумаб, Therapeutic strategy, business.industry, Genetically engineered, secukinumab, эффективность, Treat to target, psoriasis, lcsh:RL1-803, medicine.disease, безопасность, efficiency, 030220 oncology & carcinogenesis, устойчивость терапии, Secukinumab, генно-инженерные биологические препараты, IL17A, therapy persistence, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03089de57f6c8d5ec1d53b9a6d7f13aaTest
https://www.vestnikdv.ru/jour/article/view/267Test